Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 27 04:00PM ET
1.25
Dollar change
0.00
Percentage change
0.00
%
IndexRUT P/E40.45 EPS (ttm)0.03 Insider Own14.11% Shs Outstand72.95M Perf Week-6.72%
Market Cap91.31M Forward P/E1.54 EPS next Y0.81 Insider Trans0.63% Shs Float62.74M Perf Month-19.87%
Income8.31M PEG1.62 EPS next Q- Inst Own14.05% Short Float10.64% Perf Quarter-32.07%
Sales65.49M P/S1.39 EPS this Y133.33% Inst Trans-5.54% Short Ratio20.31 Perf Half Y-23.78%
Book/sh0.46 P/B2.72 EPS next Y285.71% ROA11.86% Short Interest6.67M Perf Year-40.48%
Cash/sh0.61 P/C2.05 EPS next 5Y25.00% ROE72.50% 52W Range1.21 - 3.55 Perf YTD-29.78%
Dividend Est.- P/FCF- EPS past 5Y- ROI21.76% 52W High-64.79% Beta0.89
Dividend TTM- Quick Ratio1.12 Sales past 5Y19.48% Gross Margin64.91% 52W Low3.73% ATR (14)0.07
Dividend Ex-Date- Current Ratio1.54 EPS Y/Y TTM140.65% Oper. Margin15.97% RSI (14)37.31 Volatility5.32% 5.31%
Employees208 Debt/Eq0.78 Sales Y/Y TTM37.48% Profit Margin12.69% Recom1.00 Target Price13.00
Option/ShortYes / Yes LT Debt/Eq0.14 EPS Q/Q-13.74% Payout0.00% Rel Volume0.00 Prev Close1.25
Sales Surprise28.58% EPS Surprise-20.00% Sales Q/Q21.69% EarningsMar 14 BMO Avg Volume328.70K Price1.25
SMA20-10.87% SMA50-14.01% SMA200-24.67% Trades Volume0 Change0.00%
Date Action Analyst Rating Change Price Target Change
Jun-08-20Reiterated H.C. Wainwright Buy $3 → $11
Apr-17-17Reiterated Rodman & Renshaw Buy $4 → $5
Apr-04-16Initiated Rodman & Renshaw Buy $3.50
Apr-23-15Upgrade Jefferies Hold → Buy $2 → $2.60
Nov-12-14Reiterated R. F. Lafferty Buy $8 → $5
Jan-24-14Initiated R. F. Lafferty Buy $8
May-02-12Reiterated Oppenheimer Outperform $9 → $11
May-02-12Downgrade Canaccord Genuity Buy → Hold $8 → $8
Apr-30-12Downgrade Auriga Buy → Hold $8 → $8
Oct-13-11Initiated Morgan Joseph Hold
Mar-15-24 01:17PM
Mar-14-24 08:11AM
06:50AM
Mar-07-24 06:50AM
Feb-23-24 06:50AM
06:50AM Loading…
Dec-26-23 06:50AM
Nov-30-23 04:00AM
Nov-07-23 09:04AM
Nov-06-23 08:04AM
06:58AM
06:50AM
Oct-30-23 06:50AM
Oct-09-23 06:50AM
Sep-12-23 06:50AM
Sep-06-23 06:50AM
09:14AM Loading…
Aug-08-23 09:14AM
06:51AM
Aug-07-23 06:50AM
Aug-01-23 06:50AM
Jul-31-23 06:50AM
Jun-08-23 06:50AM
May-30-23 11:00AM
06:50AM
May-23-23 06:50AM
May-18-23 06:50AM
May-11-23 07:59AM
May-10-23 04:16PM
06:00AM
May-08-23 02:32AM
May-05-23 07:26AM
06:46AM Loading…
06:46AM
May-04-23 06:50AM
Apr-27-23 06:50AM
Mar-21-23 06:50AM
Mar-13-23 06:50AM
Feb-28-23 08:52PM
04:32AM
Feb-27-23 06:30AM
Feb-24-23 09:15AM
Feb-21-23 06:55AM
06:50AM
Jan-06-23 07:04AM
Jan-03-23 06:50AM
Dec-21-22 04:30PM
Dec-05-22 06:50AM
Dec-04-22 09:00AM
Nov-30-22 02:59PM
Nov-15-22 04:46AM
Nov-14-22 06:50AM
06:30AM
Nov-07-22 06:50AM
Sep-21-22 08:00AM
Sep-12-22 12:40PM
Sep-06-22 06:50AM
Aug-16-22 05:55AM
Aug-15-22 06:50AM
Aug-08-22 06:50AM
Jun-30-22 04:30PM
Jun-14-22 09:23AM
May-26-22 04:30PM
May-17-22 06:13AM
May-16-22 06:50AM
May-09-22 06:50AM
Apr-07-22 10:05AM
Apr-05-22 07:40AM
Apr-04-22 06:50AM
Apr-01-22 06:22AM
Mar-31-22 06:50AM
Mar-24-22 06:50AM
Mar-18-22 09:54AM
06:50AM
Mar-07-22 07:00AM
Feb-28-22 04:45AM
Feb-24-22 07:27AM
Feb-03-22 06:50AM
Dec-22-21 06:50AM
Nov-15-21 10:18AM
06:50AM
Nov-08-21 06:50AM
Oct-15-21 08:37AM
08:00AM
Oct-11-21 06:50AM
Aug-26-21 06:50AM
Aug-18-21 06:06AM
Aug-16-21 06:50AM
Aug-13-21 06:50AM
Aug-09-21 07:15AM
Aug-02-21 06:50AM
Jun-30-21 09:56AM
Jun-28-21 06:50AM
Jun-07-21 10:18PM
Jun-05-21 08:16PM
Jun-03-21 09:28AM
09:28AM
12:30AM
Jun-02-21 12:10PM
06:50AM
May-25-21 06:50AM
May-14-21 06:50AM
06:45AM
Protalix Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development, production, and commercialization of recombinant therapeutic proteins based on plant cell based expression system. Its products include Alidornase alfa, PRX-115 and PRX-11. The company was by Yoseph Shaaltiel in 1993 and is headquartered in Hackensack, NJ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bashan DrorPRESIDENT AND CEOOct 19 '23Buy1.4064,51690,484132,516Oct 20 06:50 AM